EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-94.30%
↓ 64% below average
Average (9y)
-57.65%
Historical baseline
Range
High:147.60%
Low:-439.11%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | -94.30% |
| 2023 | 24.66% |
| 2022 | -80.25% |
| 2021 | -48.23% |
| 2020 | 22.09% |
| 2019 | -82.16% |
| 2018 | -41.44% |
| 2017 | 14.69% |
| 2016 | -439.11% |
| 2015 | 147.60% |